{
  "data": {
    "id": "org_abpi",
    "slug": "abpi",
    "name": "Association of the British Pharmaceutical Industry",
    "short_name": "ABPI",
    "type": "association",
    "tier": 2,
    "homepage": "https://www.abpi.org.uk",
    "country_code": "GB",
    "reliability_note": null,
    "url": "https://statorigin.org/sources/abpi",
    "documents": [
      {
        "title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
        "url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
        "doc_type": "press_release",
        "published_date": null,
        "accessed_at": "2026-09-17",
        "license": "see-source",
        "url_status": "ok",
        "statistic_count": 15
      }
    ],
    "statistics": [
      {
        "id": "stat_GMYPTHCR25PSS2A2G385G7T53M",
        "url": "https://statorigin.org/stat/stat_GMYPTHCR25PSS2A2G385G7T53M",
        "indicator": {
          "slug": "branded-medicines-sales-clawback-cap",
          "name": "Branded medicines sales clawback cap",
          "definition": "Statutory or agreed ceiling on revenue clawback rates applied to branded prescription medicine sales."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GB",
          "name": "United Kingdom",
          "type": "country"
        },
        "period": {
          "start": "2026-09-08",
          "end": "2026-09-08",
          "type": "point"
        },
        "value": 15,
        "value_text": "15 per cent",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Association of the British Pharmaceutical Industry",
          "org_short_name": "ABPI",
          "org_url": "https://www.abpi.org.uk",
          "org_tier": 2,
          "document_title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "document_url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
          "document_type": "press_release",
          "locator": "UK competitive weaknesses",
          "quote": "Despite a new 15 per cent cap on branded medicines sales clawback rates, the UK's rate on newer medicines remains higher than every other comparator country in the analysis, several of which operate no clawback system at all.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Association of the British Pharmaceutical Industry. (2026). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_GMYPTHCR25PSS2A2G385G7T53M",
          "bibtex": "@misc{abpi2026brandedg7t53m,\n  author       = {{Association of the British Pharmaceutical Industry}},\n  title        = {Green shoots for UK pharma investment, but delivery will decide whether they take root},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_GMYPTHCR25PSS2A2G385G7T53M},\n  note         = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_7SYHRJ5N94451K4W31QBHY0WD5",
        "url": "https://statorigin.org/stat/stat_7SYHRJ5N94451K4W31QBHY0WD5",
        "indicator": {
          "slug": "clinical-trial-patient-recruitment-change",
          "name": "Clinical trial patient recruitment change",
          "definition": "Percentage change in patient recruitment into clinical trials over a specified period."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GB",
          "name": "United Kingdom",
          "type": "country"
        },
        "period": {
          "start": "2022-04-01",
          "end": "2025-03-31",
          "type": "year"
        },
        "value": -25,
        "value_text": "25 per cent",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Association of the British Pharmaceutical Industry",
          "org_short_name": "ABPI",
          "org_url": "https://www.abpi.org.uk",
          "org_tier": 2,
          "document_title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "document_url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
          "document_type": "press_release",
          "locator": "UK areas of unrealised potential",
          "quote": "The gap has moved later in the process: only 58 per cent of industry trials opened to recruitment within 60 days of approval and recruitment fell by 25 per cent between 2022/23 and 2024/25, while the new network of 35 research delivery centres is outperforming the wider health system.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Association of the British Pharmaceutical Industry. (2025). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_7SYHRJ5N94451K4W31QBHY0WD5",
          "bibtex": "@misc{abpi2025clinicalhy0wd5,\n  author       = {{Association of the British Pharmaceutical Industry}},\n  title        = {Green shoots for UK pharma investment, but delivery will decide whether they take root},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_7SYHRJ5N94451K4W31QBHY0WD5},\n  note         = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_344J66GYJVV333X60WT9G7V99G",
        "url": "https://statorigin.org/stat/stat_344J66GYJVV333X60WT9G7V99G",
        "indicator": {
          "slug": "clinical-trials-recruitment-setup-timeliness-rate",
          "name": "Clinical trials recruitment setup timeliness rate",
          "definition": "Share of approved clinical trials initiated for patient recruitment within designated time limits."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GB",
          "name": "United Kingdom",
          "type": "country"
        },
        "period": {
          "start": "2026-09-08",
          "end": "2026-09-08",
          "type": "point"
        },
        "value": 58,
        "value_text": "58 per cent",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Association of the British Pharmaceutical Industry",
          "org_short_name": "ABPI",
          "org_url": "https://www.abpi.org.uk",
          "org_tier": 2,
          "document_title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "document_url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
          "document_type": "press_release",
          "locator": "UK areas of unrealised potential",
          "quote": "The gap has moved later in the process: only 58 per cent of industry trials opened to recruitment within 60 days of approval and recruitment fell by 25 per cent between 2022/23 and 2024/25, while the new network of 35 research delivery centres is outperforming the wider health system.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Association of the British Pharmaceutical Industry. (2026). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_344J66GYJVV333X60WT9G7V99G",
          "bibtex": "@misc{abpi2026clinicalg7v99g,\n  author       = {{Association of the British Pharmaceutical Industry}},\n  title        = {Green shoots for UK pharma investment, but delivery will decide whether they take root},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_344J66GYJVV333X60WT9G7V99G},\n  note         = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_T3CXFB2BQRJRCBTF1RHGA9JZF2",
        "url": "https://statorigin.org/stat/stat_T3CXFB2BQRJRCBTF1RHGA9JZF2",
        "indicator": {
          "slug": "clinical-trials-regulatory-approval-timeliness-rate",
          "name": "Clinical trials regulatory approval timeliness rate",
          "definition": "Share of clinical trial applications receiving regulatory approval decisions within standard timeframes."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GB",
          "name": "United Kingdom",
          "type": "country"
        },
        "period": {
          "start": "2026-09-08",
          "end": "2026-09-08",
          "type": "point"
        },
        "value": 98,
        "value_text": "98 per cent",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Association of the British Pharmaceutical Industry",
          "org_short_name": "ABPI",
          "org_url": "https://www.abpi.org.uk",
          "org_tier": 2,
          "document_title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "document_url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
          "document_type": "press_release",
          "locator": "UK areas of unrealised potential",
          "quote": "Study set-up has improved, with 98 per cent of trials receiving regulatory approval within 60 days, though patient recruitment continues to decline and requires attention across the whole trial journey.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Association of the British Pharmaceutical Industry. (2026). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_T3CXFB2BQRJRCBTF1RHGA9JZF2",
          "bibtex": "@misc{abpi2026clinicala9jzf2,\n  author       = {{Association of the British Pharmaceutical Industry}},\n  title        = {Green shoots for UK pharma investment, but delivery will decide whether they take root},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_T3CXFB2BQRJRCBTF1RHGA9JZF2},\n  note         = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_BQ5XYTBPZ1H5M9TNFTWWVTV9EP",
        "url": "https://statorigin.org/stat/stat_BQ5XYTBPZ1H5M9TNFTWWVTV9EP",
        "indicator": {
          "slug": "innovative-medicines-spending-target-share-of-gdp",
          "name": "Innovative medicines spending target share of GDP",
          "definition": "Targeted government expenditure on innovative medicines expressed as a percentage of gross domestic product."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GB",
          "name": "United Kingdom",
          "type": "country"
        },
        "period": {
          "start": "2026-09-08",
          "end": "2026-09-08",
          "type": "point"
        },
        "value": 0.6,
        "value_text": "0.6%",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "forecast",
        "source": {
          "org": "Association of the British Pharmaceutical Industry",
          "org_short_name": "ABPI",
          "org_url": "https://www.abpi.org.uk",
          "org_tier": 2,
          "document_title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "document_url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
          "document_type": "press_release",
          "locator": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "quote": "These investments have been made possible through collaboration between industry and government, alongside a combination of short- and long-term policy commitments, including an increase to the baseline cost-benefit threshold used by NICE and a commitment to increase UK investment in innovative medicines to 0.6% of GDP.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Association of the British Pharmaceutical Industry. (2026). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_BQ5XYTBPZ1H5M9TNFTWWVTV9EP",
          "bibtex": "@misc{abpi2026innovativevtv9ep,\n  author       = {{Association of the British Pharmaceutical Industry}},\n  title        = {Green shoots for UK pharma investment, but delivery will decide whether they take root},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_BQ5XYTBPZ1H5M9TNFTWWVTV9EP},\n  note         = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_THEHPHHJZD2K4WC9RAAR4S1G7P",
        "url": "https://statorigin.org/stat/stat_THEHPHHJZD2K4WC9RAAR4S1G7P",
        "indicator": {
          "slug": "median-drug-approval-time-count",
          "name": "Median drug approval time (count)",
          "definition": "Median duration in days required by a regulatory authority to approve a new active substance application."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GB",
          "name": "United Kingdom",
          "type": "country"
        },
        "period": {
          "start": "2024-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 427,
        "value_text": "427 days",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Association of the British Pharmaceutical Industry",
          "org_short_name": "ABPI",
          "org_url": "https://www.abpi.org.uk",
          "org_tier": 2,
          "document_title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "document_url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
          "document_type": "press_release",
          "locator": "UK areas of unrealised potential",
          "quote": "The MHRA's median time to approve a new medicine fell from 427 days in 2024 to 378 days in 2025, alongside improvements in the reliability of scientific advice and clinical trial approvals.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Association of the British Pharmaceutical Industry. (2024). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_THEHPHHJZD2K4WC9RAAR4S1G7P",
          "bibtex": "@misc{abpi2024median4s1g7p,\n  author       = {{Association of the British Pharmaceutical Industry}},\n  title        = {Green shoots for UK pharma investment, but delivery will decide whether they take root},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_THEHPHHJZD2K4WC9RAAR4S1G7P},\n  note         = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_2AWYKEAD5VHV9KAB0XWHNEFZ3D",
        "url": "https://statorigin.org/stat/stat_2AWYKEAD5VHV9KAB0XWHNEFZ3D",
        "indicator": {
          "slug": "median-drug-approval-time-count",
          "name": "Median drug approval time (count)",
          "definition": "Median duration in days required by a regulatory authority to approve a new active substance application."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GB",
          "name": "United Kingdom",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 378,
        "value_text": "378 days",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Association of the British Pharmaceutical Industry",
          "org_short_name": "ABPI",
          "org_url": "https://www.abpi.org.uk",
          "org_tier": 2,
          "document_title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "document_url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
          "document_type": "press_release",
          "locator": "UK areas of unrealised potential",
          "quote": "The MHRA's median time to approve a new medicine fell from 427 days in 2024 to 378 days in 2025, alongside improvements in the reliability of scientific advice and clinical trial approvals.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Association of the British Pharmaceutical Industry. (2025). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_2AWYKEAD5VHV9KAB0XWHNEFZ3D",
          "bibtex": "@misc{abpi2025mediannefz3d,\n  author       = {{Association of the British Pharmaceutical Industry}},\n  title        = {Green shoots for UK pharma investment, but delivery will decide whether they take root},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_2AWYKEAD5VHV9KAB0XWHNEFZ3D},\n  note         = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_TBT0EHZB6AJK58HZ51FA8ABSBW",
        "url": "https://statorigin.org/stat/stat_TBT0EHZB6AJK58HZ51FA8ABSBW",
        "indicator": {
          "slug": "new-medicines-availability-rate",
          "name": "New medicines availability rate",
          "definition": "Percentage of newly approved medicines made fully accessible for their licensed indications."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GB",
          "name": "United Kingdom",
          "type": "country"
        },
        "period": {
          "start": "2021-01-01",
          "end": "2024-12-31",
          "type": "year"
        },
        "value": 33,
        "value_text": "33 per cent",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Association of the British Pharmaceutical Industry",
          "org_short_name": "ABPI",
          "org_url": "https://www.abpi.org.uk",
          "org_tier": 2,
          "document_title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "document_url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
          "document_type": "press_release",
          "locator": "UK competitive weaknesses",
          "quote": "Just 33 per cent of new medicines were made fully available for their licensed use in 2021–24, and the UK ranks last among European comparators for how adoption of new, innovative medicines.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Association of the British Pharmaceutical Industry. (2024). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_TBT0EHZB6AJK58HZ51FA8ABSBW",
          "bibtex": "@misc{abpi2024medicines8absbw,\n  author       = {{Association of the British Pharmaceutical Industry}},\n  title        = {Green shoots for UK pharma investment, but delivery will decide whether they take root},\n  year         = {2024},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_TBT0EHZB6AJK58HZ51FA8ABSBW},\n  note         = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_PHN2SMK3W3WFKN506YA8B0D87N",
        "url": "https://statorigin.org/stat/stat_PHN2SMK3W3WFKN506YA8B0D87N",
        "indicator": {
          "slug": "newer-medicines-clawback-rate",
          "name": "Newer medicines clawback rate",
          "definition": "Effective revenue clawback rate applied to sales of newly marketed branded prescription medicines."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GB",
          "name": "United Kingdom",
          "type": "country"
        },
        "period": {
          "start": "2025-01-01",
          "end": "2025-12-31",
          "type": "year"
        },
        "value": 22.9,
        "value_text": "22.9 per cent",
        "unit": "percent",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Association of the British Pharmaceutical Industry",
          "org_short_name": "ABPI",
          "org_url": "https://www.abpi.org.uk",
          "org_tier": 2,
          "document_title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "document_url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
          "document_type": "press_release",
          "locator": "UK competitive weaknesses",
          "quote": "The trend is now downwards, however: the newer medicines rate has fallen to 14.5 per cent in 2026 from a 2025 peak of 22.9 per cent, and agreeing a stable, internationally competitive scheme model from 2029 is the next milestone.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Association of the British Pharmaceutical Industry. (2025). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_PHN2SMK3W3WFKN506YA8B0D87N",
          "bibtex": "@misc{abpi2025newerb0d87n,\n  author       = {{Association of the British Pharmaceutical Industry}},\n  title        = {Green shoots for UK pharma investment, but delivery will decide whether they take root},\n  year         = {2025},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_PHN2SMK3W3WFKN506YA8B0D87N},\n  note         = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_WTQE0KC0QBPEP8G4JJDNJJJ8P5",
        "url": "https://statorigin.org/stat/stat_WTQE0KC0QBPEP8G4JJDNJJJ8P5",
        "indicator": {
          "slug": "pharmaceutical-direct-gross-value-added",
          "name": "Pharmaceutical direct gross value added",
          "definition": "Annual direct gross value added generated by the pharmaceutical industry."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GB",
          "name": "United Kingdom",
          "type": "country"
        },
        "period": {
          "start": "2026-09-08",
          "end": "2026-09-08",
          "type": "point"
        },
        "value": 20.4,
        "value_text": "£20.4 billion",
        "unit": "GBP",
        "currency": "GBP",
        "scale": "billion",
        "value_type": "actual",
        "source": {
          "org": "Association of the British Pharmaceutical Industry",
          "org_short_name": "ABPI",
          "org_url": "https://www.abpi.org.uk",
          "org_tier": 2,
          "document_title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "document_url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
          "document_type": "press_release",
          "locator": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "quote": "If investment and growth accelerate, it could create as many as 81,300 new jobs by 2035, expanding the pharmaceutical workforce to around 200,000 people and generating £33.4 billion of direct Gross Value Added each year, up from £20.4 billion today.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Association of the British Pharmaceutical Industry. (2026). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_WTQE0KC0QBPEP8G4JJDNJJJ8P5",
          "bibtex": "@misc{abpi2026pharmaceuticaljjj8p5,\n  author       = {{Association of the British Pharmaceutical Industry}},\n  title        = {Green shoots for UK pharma investment, but delivery will decide whether they take root},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_WTQE0KC0QBPEP8G4JJDNJJJ8P5},\n  note         = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_8NMD6PF91NZSBPDMGZCN5PS78Q",
        "url": "https://statorigin.org/stat/stat_8NMD6PF91NZSBPDMGZCN5PS78Q",
        "indicator": {
          "slug": "pharmaceutical-industry-employment",
          "name": "Pharmaceutical industry employment",
          "definition": "Total number of direct and supported persons employed in the pharmaceutical industry."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GB",
          "name": "United Kingdom",
          "type": "country"
        },
        "period": {
          "start": "2026-09-08",
          "end": "2026-09-08",
          "type": "point"
        },
        "value": 125000,
        "value_text": "125,000",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Association of the British Pharmaceutical Industry",
          "org_short_name": "ABPI",
          "org_url": "https://www.abpi.org.uk",
          "org_tier": 2,
          "document_title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "document_url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
          "document_type": "press_release",
          "locator": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "quote": "The pharmaceutical industry already supports more than 125,000 jobs across every UK nation and region.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Association of the British Pharmaceutical Industry. (2026). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_8NMD6PF91NZSBPDMGZCN5PS78Q",
          "bibtex": "@misc{abpi2026pharmaceutical5ps78q,\n  author       = {{Association of the British Pharmaceutical Industry}},\n  title        = {Green shoots for UK pharma investment, but delivery will decide whether they take root},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_8NMD6PF91NZSBPDMGZCN5PS78Q},\n  note         = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_A2AVF49TQ1Z8WBJ1MJFXMMV18S",
        "url": "https://statorigin.org/stat/stat_A2AVF49TQ1Z8WBJ1MJFXMMV18S",
        "indicator": {
          "slug": "pharmaceutical-industry-investment-commitments",
          "name": "Pharmaceutical industry investment commitments",
          "definition": "Total monetary value of capital and development investment commitments pledged by the pharmaceutical industry."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GB",
          "name": "United Kingdom",
          "type": "country"
        },
        "period": {
          "start": "2025-09-01",
          "end": "2026-09-08",
          "type": "year"
        },
        "value": 2,
        "value_text": "£2 billion",
        "unit": "GBP",
        "currency": "GBP",
        "scale": "billion",
        "value_type": "actual",
        "source": {
          "org": "Association of the British Pharmaceutical Industry",
          "org_short_name": "ABPI",
          "org_url": "https://www.abpi.org.uk",
          "org_tier": 2,
          "document_title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "document_url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
          "document_type": "press_release",
          "locator": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "quote": "Since September 2025, the global pharmaceutical industry has committed an additional £2 billion of investment into the UK, spanning the value chain from AI-enabled discovery science to large-scale medicines manufacturing.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Association of the British Pharmaceutical Industry. (2026). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_A2AVF49TQ1Z8WBJ1MJFXMMV18S",
          "bibtex": "@misc{abpi2026pharmaceuticalmmv18s,\n  author       = {{Association of the British Pharmaceutical Industry}},\n  title        = {Green shoots for UK pharma investment, but delivery will decide whether they take root},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_A2AVF49TQ1Z8WBJ1MJFXMMV18S},\n  note         = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_HBZF82HRY28PZB32B0RW04MB3S",
        "url": "https://statorigin.org/stat/stat_HBZF82HRY28PZB32B0RW04MB3S",
        "indicator": {
          "slug": "projected-pharmaceutical-direct-gross-value-added",
          "name": "Projected pharmaceutical direct gross value added",
          "definition": "Projected annual direct gross value added generated by the pharmaceutical industry."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GB",
          "name": "United Kingdom",
          "type": "country"
        },
        "period": {
          "start": "2035-01-01",
          "end": "2035-12-31",
          "type": "year"
        },
        "value": 33.4,
        "value_text": "£33.4 billion",
        "unit": "GBP",
        "currency": "GBP",
        "scale": "billion",
        "value_type": "forecast",
        "source": {
          "org": "Association of the British Pharmaceutical Industry",
          "org_short_name": "ABPI",
          "org_url": "https://www.abpi.org.uk",
          "org_tier": 2,
          "document_title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "document_url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
          "document_type": "press_release",
          "locator": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "quote": "If investment and growth accelerate, it could create as many as 81,300 new jobs by 2035, expanding the pharmaceutical workforce to around 200,000 people and generating £33.4 billion of direct Gross Value Added each year, up from £20.4 billion today.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Association of the British Pharmaceutical Industry. (2035). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_HBZF82HRY28PZB32B0RW04MB3S",
          "bibtex": "@misc{abpi2035projected04mb3s,\n  author       = {{Association of the British Pharmaceutical Industry}},\n  title        = {Green shoots for UK pharma investment, but delivery will decide whether they take root},\n  year         = {2035},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_HBZF82HRY28PZB32B0RW04MB3S},\n  note         = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_Q8V7B7Z3DZS4MQVC9RWT8QD7BA",
        "url": "https://statorigin.org/stat/stat_Q8V7B7Z3DZS4MQVC9RWT8QD7BA",
        "indicator": {
          "slug": "projected-pharmaceutical-employment",
          "name": "Projected pharmaceutical employment",
          "definition": "Projected total employment in the pharmaceutical industry under specified economic scenarios."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GB",
          "name": "United Kingdom",
          "type": "country"
        },
        "period": {
          "start": "2035-01-01",
          "end": "2035-12-31",
          "type": "year"
        },
        "value": 200000,
        "value_text": "200,000",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "forecast",
        "source": {
          "org": "Association of the British Pharmaceutical Industry",
          "org_short_name": "ABPI",
          "org_url": "https://www.abpi.org.uk",
          "org_tier": 2,
          "document_title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "document_url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
          "document_type": "press_release",
          "locator": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "quote": "If investment and growth accelerate, it could create as many as 81,300 new jobs by 2035, expanding the pharmaceutical workforce to around 200,000 people and generating £33.4 billion of direct Gross Value Added each year, up from £20.4 billion today.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Association of the British Pharmaceutical Industry. (2035). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_Q8V7B7Z3DZS4MQVC9RWT8QD7BA",
          "bibtex": "@misc{abpi2035projected8qd7ba,\n  author       = {{Association of the British Pharmaceutical Industry}},\n  title        = {Green shoots for UK pharma investment, but delivery will decide whether they take root},\n  year         = {2035},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_Q8V7B7Z3DZS4MQVC9RWT8QD7BA},\n  note         = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_59843GJR4G04K6ZCXSWZZE46SW",
        "url": "https://statorigin.org/stat/stat_59843GJR4G04K6ZCXSWZZE46SW",
        "indicator": {
          "slug": "projected-pharmaceutical-job-creation",
          "name": "Projected pharmaceutical job creation",
          "definition": "Projected number of net new jobs created in the pharmaceutical sector over a forecast period."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GB",
          "name": "United Kingdom",
          "type": "country"
        },
        "period": {
          "start": "2026-09-08",
          "end": "2035-12-31",
          "type": "point"
        },
        "value": 81300,
        "value_text": "81,300",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "forecast",
        "source": {
          "org": "Association of the British Pharmaceutical Industry",
          "org_short_name": "ABPI",
          "org_url": "https://www.abpi.org.uk",
          "org_tier": 2,
          "document_title": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "document_url": "https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/",
          "document_type": "press_release",
          "locator": "Green shoots for UK pharma investment, but delivery will decide whether they take root",
          "quote": "If investment and growth accelerate, it could create as many as 81,300 new jobs by 2035, expanding the pharmaceutical workforce to around 200,000 people and generating £33.4 billion of direct Gross Value Added each year, up from £20.4 billion today.",
          "published_date": null,
          "accessed_at": "2026-09-17",
          "license": "see-source",
          "url_status": "ok"
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Association of the British Pharmaceutical Industry. (2035). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_59843GJR4G04K6ZCXSWZZE46SW",
          "bibtex": "@misc{abpi2035projectedze46sw,\n  author       = {{Association of the British Pharmaceutical Industry}},\n  title        = {Green shoots for UK pharma investment, but delivery will decide whether they take root},\n  year         = {2035},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_59843GJR4G04K6ZCXSWZZE46SW},\n  note         = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      }
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 15,
    "note": "Statistics are capped at 100 per request. Use /statistics?source_org=abpi with a cursor to page through everything."
  }
}